
Senolytic research peptide
FOXO4-DRI
FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the interaction between the FOXO4 transcription factor and p53.
Size
Bulk pricing
What is FOXO4-DRI?
FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the interaction between the FOXO4 transcription factor and p53. First described in 2017, it is studied in research on senescent cells and selective senolysis.
Specifications
| Product | FOXO4-DRI |
|---|---|
| Class | D-retro-inverso peptide |
| Size | 10 mg per vial |
| Form | Lyophilized powder in sealed glass vial |
| Storage | −20 °C, protected from light and moisture |
| Documentation | Certificate of Analysis on request |
| Ships from | British Columbia, Canada |
Shipping FOXO4-DRI in Canada
Every order of FOXO4-DRI ships from British Columbia in discreet, unbranded packaging with tracking. Orders leave within 1–2 business days and most arrive in 2–5 business days — with no customs forms or border delays. Orders over $300 ship free. See our guide to buying research peptides in Canada for more.
FOXO4-DRI FAQ
Can I buy FOXO4-DRI in Canada?
Yes. RevitaCore sells FOXO4-DRI (10 mg) as a research material and ships it from British Columbia to addresses across Canada, so orders never pass through customs.
Are these peptides for human use?
No. All RevitaCore products are sold strictly for in-vitro laboratory research. They are not approved by Health Canada and are not for human or veterinary use.
How should lyophilized peptides be stored?
Sealed lyophilized vials are best kept at −20 °C, protected from light and moisture. Short periods at room temperature during shipping are normal for freeze-dried material.
How fast is shipping?
Orders ship from British Columbia within 1–2 business days and most arrive 2–5 business days after dispatch. Orders over $300 ship free.


